HCP AI Use and Trust Gap – an Oncology Deep Dive

Mark Bard, co-founder and managing partner of The DHC Group, sat down with Matt Holland, COO of Healio, at this year’s Fierce Pharma Week to unpack how AI is reshaping physician trust, content, and market research.

Point-of-Care Marketing: From Supporting Channel to Center Stage

The Point of Care Now Summit 2026 made one thing unmistakably clear: point-of-care is no longer an emerging space. It has arrived. What was once considered to be an auxiliary channel has now crossed $1 billion in pharma investment, spanning both patient and HCP budgets. The energy at this year’s summit reflected that shift.

Go to Top